Today's Healthcare Pulse
FDA greenlights four new oncology products, expanding treatment options
The FDA approved four oncology products in mid‑June 2026, including AstraZeneca’s Truqap for PTEN‑deficient metastatic prostate cancer, Roche’s VENTANA PTEN companion diagnostic, Bayer’s low‑dose MRI contrast agent Ambelvist, and MSD’s Keytruda‑Welireg combo for high‑risk renal cell carcinoma. Truqap demonstrated a 19% reduction in disease‑progression risk and added 7.5 months of progression‑free survival. The approvals were reported by multiple outlets.
Also developing:
UK Firm Steps in to Ease Medicine Supply Crisis in NHS
A shortage of bone cement from German supplier Heraeus Medical threatens NHS orthopaedic surgeries, potentially lasting two months. NHS England has asked trusts to prioritise emergency joint replacements, leaving elective patients at risk. UK‑based Biocomposites accelerated the launch of its Synicem bone cement, aiming to produce one million packs annually to fill the gap. The crisis has prompted political scrutiny and regulatory action, including the House of Lords’ warning and the MHRA’s Project Revive pilot.
Novartis to Divest India Unit to Private Equity-Led Consortium for $159M
Novartis announced the sale of its majority stake in its Indian generics and prescription business to a private‑equity‑led consortium for $159 million. The transaction transfers control of a portfolio that includes both off‑patent generics and branded medicines to the buyers. The...
Why “Eat Less, Move More” Fails for Midlife Weight Loss
Midlife women often follow the classic "eat less, move more" mantra yet see stagnant scales because perimenopause and menopause trigger profound physiological shifts. Hormonal fluctuations raise insulin and cortisol, blunt glucose flexibility, and promote fat oxidation over muscle use. Simultaneously,...
Stratasys Introduces 3D-Printed Dental Training Preset
Stratasys unveiled a new dental anatomical model preset that leverages its multi‑material 3D printing platform to produce highly detailed, biomechanically accurate replicas for dental education and device training. The preset standardizes material ratios and printing parameters, enabling on‑demand, repeatable models...
Levetiracetam Reduces Amyloid-Β Production in the Brain
Researchers report that the FDA‑approved antiepileptic levetiracetam reduces amyloid‑β42 production in mouse models of Alzheimer’s disease. The drug redirects amyloid precursor protein processing toward the non‑amyloidogenic pathway by modifying synaptic vesicle cycling and increasing surface APP expression. Mass‑spectrometry and electrophysiology...
Nobody Gets Sued but the Doctor: The Legal Vacuum at the Center of the AI Physician Revolution
The episode examines the legal vacuum surrounding AI‑assisted clinical decision‑making, highlighting that while the FDA has cleared over 1,300 AI medical devices, adoption remains low and physicians bear virtually all malpractice liability. Data shows a rapid rise in AI use...
Kontakt.io Unveils Next-Generation AI Solutions to Re-ViVE Care Operations and Transform Healthcare Delivery
Kontakt.io announced a suite of AI‑driven agents at ViVE 2026, combining real‑time location services (RTLS) with electronic health record data to create a digital twin of hospital operations. The portfolio—Patient Journey Analytics, Access Agent, Patient Flow Agent, and Supply Chain...
Pontiro Secures £357,500 to Expand Healthcare AI Infrastructure
Pontiro, a health‑tech firm that streamlines medical‑image data for AI, secured £357,500 in a round led by SFC Capital with participation from Plug and Play Ventures and the British Business Bank. The company’s platform has already processed more than two...
Pharma Pulse: J&J’s $1B Cell Therapy Hub and Hims & Hers’ Global Expansion
Johnson & Johnson announced a $1 billion investment to build a next‑generation cell‑therapy manufacturing facility in Montgomery County, Pennsylvania, slated to support 500 skilled jobs. The hub is a key element of J&J’s $55 billion U.S. manufacturing, R&D, and technology strategy. Meanwhile,...
NKTR’s Alopecia Areata Play: Market Misprices Massive Upside
Ok, so I have finally gotten around to writing out my updated thoughts/thesis on $NKTR. Link in this post. I'm about as bullish on the stock now as I've ever been. The document is very long (sorry, but it's free...give me...
Ex-Novartis CMO John Tsai Joins Daiichi Sankyo
Daiichi Sankyo appointed former Novartis chief medical officer John Tsai as its new CMO, succeeding Ken Takeshita after a five‑year tenure. Tsai brings a record of launching 160 projects and 15 regulatory approvals, including Zolgensma and Pluvicto, and recent experience leading biotech...
NexEos Bio Receives US FDA IND Clearance to Advance NTX-1024 Into P-II/III Study for Vernal Keratoconjunctivitis
U.S. FDA has granted IND clearance for NexEos Bio’s ophthalmic solution NTX-1024, allowing the company to commence a combined Phase II/III clinical trial in vernal keratoconjunctivitis (VKC). The upcoming study will assess safety and efficacy after an open‑label investigator‑initiated trial...
Boehringer Ingelheim and NIPER Sign MoU on Pharmaceutical Research
Boehringer Ingelheim India has signed a memorandum of understanding with the National Institute of Pharmaceutical Education and Research (NIPER) in Raebareli to deepen collaboration on pharmaceutical technologies and novel drug delivery systems. The agreement grants NIPER access to Boehringer’s opnMe...
AZN's Calquence + Venetoclax Approved for CLL Treatment
#AZN Calquence combined with Venetoclax approved in US for treating Adults with Chronic Lymphocytic Leukaemia in a particular form.
How Medical Device Manufacturers Can Overcome Recruitment Gaps and Accelerate Innovation Hiring with Rapid Prototyping
Medical device makers face a perfect storm of innovation pressure and a severe talent shortage, causing development cycles to stretch 18‑24 months. Rapid prototyping technologies can compress these cycles by up to 40%, enabling faster design iteration and ISO 13485‑compliant...
En Carta Diagnostics Receives FDA Breakthrough Device Designation for EC Pocket Lyme Test
En Carta Diagnostics announced that its EC Pocket Lyme test has received FDA Breakthrough Device Designation, accelerating its path to U.S. market entry. The point‑of‑need molecular assay detects Borrelia DNA directly from skin interstitial fluid using a microneedle sampler, delivering...
Nurses Aren’t Burned Out, They’re Being Burned by the System
Recent data shows 53% of nurses consider leaving monthly, indicating systemic burnout. The national turnover rate of 16.4% costs about $61,110 per replacement, harming patient care and morale. HR leaders must address root causes—understaffing, erratic schedules, limited autonomy—through workforce planning,...
AngioDynamics Expands European Indications for NanoKnife System
AngioDynamics announced that its NanoKnife system now holds European CE‑mark indications for soft‑tissue ablation of liver, kidney, prostate and pancreas tumours, including intermediate‑risk prostate cancer. The device uses irreversible electroporation (IRE), a non‑thermal technology that destroys cancer cells while sparing...
Serina Therapeutics Enrols First Patient for SER-252 Trial
Serina Therapeutics has enrolled the first patient in its Phase Ib registrational trial of SER‑252 for advanced Parkinson’s disease. The study, conducted with Parkinson’s Australia and Neuroscience Trials Australia, will assess safety, pharmacokinetics, tolerability and early efficacy, with dosing slated to...
Syngene and VivaMed Collaborate on Therapeutic Programmes
Syngene International has entered a strategic collaboration with VivaMed BioPharma to advance AI‑derived drug repurposing programmes. The partnership combines Syngene’s pre‑clinical development capabilities with VivaMed’s AI‑generated therapeutic hypotheses, creating a pathway from computational hits to translational validation. Together they will...
Application Spotlight: AI-Designed Patient-Specific Spinal Implants Set for First In-Human Procedures in 2026
Nivalon, founded by Todd Hodrinsky and Marcel Janse, is preparing to launch its AI‑designed, patient‑specific spinal implant system, EvoFlex, in first‑in‑human trials slated for 2026. The implants are generated through machine‑learning algorithms that model each patient’s vertebral geometry, aiming to...
Accelerating Rare Disease Cures with ASOs, Gene Editing, and AI
Professor Matthew Wood, Oxford’s leading neuroscientist, heads the Oxford‑Harrington Rare Disease Centre, a partnership designed to fast‑track therapies for rare neuromuscular and genetic disorders. He outlines a vision to make antisense oligonucleotides (ASOs) and gene‑editing tools more modular, scalable, and...
4.2m Eye Health Research Hub Set for North East
A £4.2 million Northern Ophthalmic Research and Innovation Institute (NORI) is being established in North East England to turn routine eye scans into early‑warning tools for serious illnesses. The hub, hosted by the University of Sunderland, will link eye images with...
AM Best’s Briefing – Health: Medicare Advantage – Challenges and Opportunities
The episode provides an overview of the current Medicare Advantage (MA) landscape, highlighting regulatory changes, enrollment trends, and financial pressures facing insurers. It examines challenges such as rising cost of care, tighter network requirements, and the impact of the Medicare...
Leica Launches CM1950 Cryostat with DualEcoTec Cooling System
Leica Biosystems, a Danaher subsidiary, unveiled the Leica CM1950 cryostat equipped with DualEcoTec cooling. The device cools specimens up to three times faster and chambers up to twice as fast, slashing setup and case times. It employs a near‑zero global...
Boehringer Ingelheim Secures US FDA’s EUA for NexGard and NexGard COMBO to Treat NWS
Boehringer Ingelheim received an Emergency Use Authorization (EUA) from the U.S. FDA for its NexGard chewable tablets to treat New World screwworm (NWS) infestations in dogs and puppies, and for NexGard COMBO topical solution to treat NWS in cats and...
It’s Time for an End to Two-Tier Tech in the NHS
The NHS is rapidly adopting AI and patient‑facing tools, yet back‑office staff such as roster managers remain stuck with outdated systems. This digital divide fuels stress, mismatched rotas, and higher temporary‑staff costs, contributing to the wider retention crisis. Trusts that...
Smart Insole to Predict and Prevent Elderly Falls
University of Bristol engineer Dr. Jiayang Li has created a smart shoe insole equipped with 253 micro‑sensors that map pressure and gait in real time. The device consumes only 100 microwatts, enabling up to three months of operation on a...
Could Medical Care Help Cure China’s Services Trade Deficit?
China’s medical tourism is gaining traction as foreign patients praise rapid, affordable care in megacities like Shanghai and Beijing. While the absolute number of inbound patients remains modest, industry insiders see a growing pipeline driven by visa‑free entry, expanding international...
Grail's Cancer Test Misses Primary Study Goal in UK Study
Grail announced that its Galleri multi‑cancer blood test failed to achieve the primary endpoint in a large United Kingdom clinical trial. The study, which evaluated the test’s ability to detect early‑stage cancers across dozens of tumor types, showed promising signals...
Rare Disease Month Developments – Part 3: The Ugly (Just Kidding) – See You at Rare Disease Week
Rare Disease Week convenes on Capitol Hill, bringing patients, advocates, regulators, and industry together to shape policy for rare disease therapies. Hyman, Phelps & McNamara will be prominently represented, highlighted by Frank Sasinowski receiving the EveryLife Foundation’s Abbey Lifetime Achievement...
HHS OCR Settles HIPAA Security Rule Investigation with Top of the World Ranch Treatment Center
The U.S. Department of Health and Human Services Office for Civil Rights settled with Top of the World Ranch Treatment Center after a phishing attack exposed ePHI for 1,980 patients. OCR fined the provider $103,000 and imposed a two‑year corrective...
Electronic Mesh Spurs Islet Cell Maturation, Could Aid Diabetes Care
Researchers at the University of Pennsylvania and Harvard have created an ultrathin, flexible electronic mesh that can be implanted into developing pancreatic tissue. The mesh delivers a 24‑hour rhythmic electrical pulse, coaxing stem‑cell‑derived islet cells toward functional maturity and synchronized...
Combining PET and MRI Data May Be Key to Differentiating New Type of Dementia
Researchers have demonstrated that combining 18F‑FDG PET with high‑resolution MRI can reliably separate limbic‑predominant age‑related TDP‑43 encephalopathy (LATE) from Alzheimer’s disease in living patients. By creating stereotactic surface projection PET templates from autopsy‑confirmed cases and integrating MRI volumetry, the team...
Vaccine Protects Against Multiple Respiratory Viruses, Bacteria, and Allergens in Mice
Stanford researchers have created an intranasal vaccine that elicits a combined innate‑adaptive response, providing broad lung protection in mice. The formulation, containing TLR agonists and a harmless antigen, shielded animals for at least three months against SARS‑CoV‑2, other coronaviruses, two...
Rising Healthcare Costs Strain Health System Margins
Healthcare spending surged as higher service volume boosted hospital revenues but also drove operating costs higher, pushing the median health‑system margin down to 1.3% in December from 1.5% in November. Labor expenses rose 4.2% year‑over‑year while supply costs jumped 12.3%,...
Cityblock Health Makes The Home ‘Even More Central,’ Expands Long-Term Services, Supports
Cityblock Health announced the rollout of its long‑term services and supports (LTSS) program across more than ten states, extending the model that began in Massachusetts and is already active in New York, North Carolina and Indiana. The offering blends regular...
Utah Launches State-Approved AI Prescription Refill Pilot as States Expand Health AI Oversight
Utah’s Department of Health has green‑lit a 12‑month pilot that lets an approved artificial‑intelligence system automatically process prescription refills for chronic medications. The AI checks dosage, patient history, and insurance eligibility before sending the order to participating pharmacies, aiming to...
Gel Helps Mini Spinal Cords to Heal From Injury
Researchers have engineered miniature, three‑dimensional spinal‑cord organoids that can be deliberately injured and subsequently repaired with a biocompatible gel. The gel promotes cell survival and rapid axonal regrowth, effectively modeling the healing cascade observed in vivo. This human‑derived platform provides...
Are Obesity Drugs Causing a Severe Complication? What the Science Says
The United Kingdom and Brazil have issued safety warnings linking GLP‑1 weight‑loss drugs to acute pancreatitis after recording 19 and 6 deaths respectively. Reports include roughly 1,300 UK and 145 Brazilian pancreatitis cases among millions of users, though the overall...
Amicus Therapeutics Inc (FOLD) Q4 2025 Earnings Call Transcript
Amgen reported double‑digit revenue and earnings growth for 2025, driven by strong performance across its oncology, rare‑disease, biosimilar and general‑medicine portfolios. Fourteen products surpassed $1 billion in sales, with Repatha, Evenity and Tespire each posting over 30% year‑over‑year growth. The company...
![[Correspondence] Why Ukraine's Energy Insecurity Is a Maternal Health Crisis](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/b09028a36dc3b49cdea2e70aeb73b513.webp)
[Correspondence] Why Ukraine's Energy Insecurity Is a Maternal Health Crisis
The Russian invasion has turned Ukraine’s energy grid into a weapon, leaving maternity hospitals without reliable power, heat, and medical equipment. Repeated strikes have caused 23 major attacks on health facilities this year, pushing premature‑birth rates to twice the national...
Healthcare Confuses PE with VC; Transparency Needed
I've noticed that PE and VC are getting lumped together by healthcare industry folks that I know as if they're the same thing. I'm not sure how we solve this problem but I suspect having more transparent conversations about it...
ViVE
ViVE 2025 convened leading health‑tech innovators to examine how security, artificial intelligence and other emerging technologies are reshaping digital health. Speakers highlighted AI‑driven diagnostics, robust cybersecurity frameworks, and interoperable platforms as essential for scaling patient‑centric care. The event also showcased...
'Digital Blood Testing' Now at Hand
A collaborative team led by UNSW and Nutromics has demonstrated a wearable patch that continuously measures vancomycin levels using DNA‑based aptamer sensors. Published in Nature Biotechnology, the pilot trial showed the patch can track drug concentration in interstitial fluid, offering...
AHA Unveils ‘We Care, We Vote’ Campaign To Engage Candidates Ahead Of Midterms
The American Hospital Association (AHA) has launched the “We Care, We Vote” campaign to mobilize its member hospitals ahead of the 2026 midterm elections. The initiative offers a dedicated website featuring voter‑registration tools, turnout guides, and a questionnaire that helps...
NSA Issues Guidelines on Zero Trust Architecture
The National Security Agency has issued a two‑phase Zero Trust Implementation Guidelines to help organizations adopt zero‑trust architecture in line with Department of Defense standards. The guidance details specific activities and requirements, acknowledging that implementation can be resource‑intensive and costly....
STAT+: Key Study of Grail’s Cancer Detection Test Fails in Setback for Company
Grail’s multi‑cancer blood test Galleri failed to meet its primary endpoint in a large NHS‑partnered study, casting doubt on its early‑detection claims. The test, priced at $1,000, generated $136.8 million from 185,000 units sold in 2025 but remains unapproved by the...
ASPR Announces Investment to Increase Domestic Production of Essential Drugs
The Administration for Strategic Preparedness and Response (ASPR) announced its first Defense Production Act Title III investment to boost U.S. manufacturing of essential drugs. The funding targets the chronic shortage of oseltamivir, the antiviral known as Tamiflu, by supporting domestic production...
Study Finds Nearly 3 Million MA Beneficiaries Forced to Find Alternative Coverage for 2026
A JAMA study released Feb 18 reveals that 10 % of Medicare Advantage (MA) beneficiaries—about 2.9 million people—must secure alternative coverage for 2026 as plans exit the market, up from 6.9 % in 2025. The displaced enrollees are disproportionately in preferred‑provider‑organization, non‑special‑needs, small‑carrier, and...